ArticlePLOS global public health2026
Adherence to National Standard Treatment Guidelines in the management of hypertension and associated factors among healthcare providers at public district hospitals in Dar es Salaam, Tanzania.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension affects 15-25% of adults in Tanzania, yet fewer than 30% of treated patients achieve blood pressure control. Poor control contributes to stroke, heart failure, and renal disease. The National Standard Treatment Guidelines (NSTGs), 6th edition (2021), provide guidance for management, but healthcare provider adherence to the guidelines remains unclear. A mixed-methods cross-sectional study was conducted at five public district hospitals in Dar es Salaam, Tanzania between 1st April and 31st May 2025. Quantitative data from patient records assessed healthcare provider adherence to pharmacological treatment, complication monitoring, and comorbidity screening, categorized as complete, partial, or non-adherent. Modified Poisson regression identified associated patient and provider factors. Qualitative data from 11 in-depth interviews were thematically analysed to explore barriers and facilitators to adherence. The median age of the 397 patients was 55 years (IQR: 52-61), 79.1% were female, 40.0% had at least one comorbidity, and 65.2% were overweight. Only 26.2% were managed with complete adherence to NSTGs. Higher adherence was associated with follow-up visits (aPR = 5.81; 95% CI: 1.59-21.27), Grade 1 hypertension (aPR = 3.87; 95% CI: 1.99-7.53), Grade 2 hypertension (aPR = 5.06; 95% CI: 1.52-16.73), comorbidities (aPR = 2.35; 95% CI: 1.25-4.41), specialist cadre (aPR = 7.00; 95% CI: 1.05-46.55), and provider experience of 5-10 years (aPR = 3.25; 95% CI: 1.17-9.03) and >10 years (aPR = 3.91; 95% CI: 1.20-12.73). Barriers included outdated guidelines, limited resources, staffing shortages, and inadequate training, while facilitators included mentorship, peer collaboration, accessible guidelines, and continuing medical education. Healthcare provider adherence to NSTGs in management of hypertension was low. Strengthening guideline implementation through updated recommendations, provider training, improved resource availability, and supportive supervision may enhance adherence and improve patient outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.